Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00124202
Other study ID # 229-2003
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received July 25, 2005
Last updated July 29, 2013
Start date May 2003
Est. completion date May 2007

Study information

Verified date July 2013
Source Emory University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is to determine if a fatty meal would improve the ERCP procedure.


Description:

A fatty meal is a potent stimulator of cholecystikinin (CCK) in human body. The biological effect of CCK is increasing bile secretion and relaxing the sphincter of Oddi. Theoretically, a fatty meal should facilitate the effect on cannulation at ERCP. If a fatty meal can make the major papilla cannulation easier, it may significantly shorten the procedure time for ERCP and even decrease complications of the procedure, since the complication rate of post-ERCP is positively related to the time of the procedure.

Comparison: Approximately one hour before ERCP procedure, patient will have a fatty meal in the study group and normal saline in control group.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date May 2007
Est. primary completion date December 2004
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients, 18 years and older, who are scheduled for ERCP at Emory University Hospital and signed consent before the procedure.

Exclusion Criteria:

- Patients with a known allergy to milk or those who choose not to sign the consent.

Study Design

Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Behavioral:
a fatty meal
Approximately one hour before ERCP procedure, patient will have a fatty meal in the study group and normal saline in control group

Locations

Country Name City State
United States Emory University School of Medicine; Emory University Hospital Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Emory University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary a fatty meal in the study group and normal saline in control group the procedure time for ERCP Yes
Secondary follow up within 3 days for complication with relation to the cannulation time within 3 days Yes
See also
  Status Clinical Trial Phase
Completed NCT00201305 - Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract Phase 2
Withdrawn NCT02118493 - Endo-biliary Laser Excision of Biliary Stenoses N/A
Recruiting NCT02524418 - Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS N/A